| GATE: a simulation toolkit for PET and SPECT S Jan, G Santin, D Strul, S Staelens, K Assié, D Autret, S Avner, R Barbier, ... Physics in Medicine & Biology 49 (19), 4543, 2004 | 2547 | 2004 |
| Phase 1 study of the Pittsburgh compound B derivative 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer disease N Nelissen, K Van Laere, L Thurfjell, R Owenius, M Vandenbulcke, ... Journal of Nuclear Medicine 50 (8), 1251-1259, 2009 | 341 | 2009 |
| Whole-body biodistribution and radiation dosimetry of 18F-GE067: a radioligand for in vivo brain amyloid imaging M Koole, DM Lewis, C Buckley, N Nelissen, M Vandenbulcke, DJ Brooks, ... Journal of Nuclear Medicine 50 (5), 818-822, 2009 | 233 | 2009 |
| Iterative reconstruction algorithms in nuclear medicine S Vandenberghe, Y D'Asseler, R Van de Walle, T Kauppinen, M Koole, ... Computerized medical imaging and graphics 25 (2), 105-111, 2001 | 216 | 2001 |
| Monte Carlo simulations of a scintillation camera using GATE: validation and application modelling S Staelens, D Strul, G Santin, S Vandenberghe, M Koole, Y D'Asseler, ... Physics in Medicine & Biology 48 (18), 3021, 2003 | 167 | 2003 |
| Bone scintigraphy with 99mtechnetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis AWJM Glaudemans, RWJ van Rheenen, MP van den Berg, W Noordzij, ... Amyloid 21 (1), 35-44, 2014 | 156 | 2014 |
| 99mTc-ECD brain perfusion SPET: variability, asymmetry and effects of age and gender in healthy adults K Van Laere, J Versijpt, K Audenaert, M Koole, I Goethals, E Achten, ... European journal of nuclear medicine 28, 873-887, 2001 | 146 | 2001 |
| Comparison of diagnostic accuracy of 111In-pentetreotide SPECT and 68Ga-DOTATOC PET/CT: A lesion-by-lesion analysis in patients with metastatic … S Van Binnebeek, B Vanbilloen, K Baete, C Terwinghe, M Koole, ... European radiology 26, 900-909, 2016 | 110 | 2016 |
| Increased expression of translocator protein (TSPO) marks pro-inflammatory microglia but does not predict neurodegeneration L Beckers, D Ory, I Geric, L Declercq, M Koole, M Kassiou, G Bormans, ... Molecular imaging and biology 20, 94-102, 2018 | 104 | 2018 |
| A standardized method for the construction of tracer specific PET and SPECT rat brain templates: validation and implementation of a toolbox D Vállez Garcia, C Casteels, AJ Schwarz, RAJO Dierckx, M Koole, ... PLoS One 10 (3), e0122363, 2015 | 101* | 2015 |
| PET imaging of tumor hypoxia using 18F-fluoroazomycin arabinoside in stage III–IV non–small cell lung cancer patients VR Bollineni, GSMA Kerner, J Pruim, RJHM Steenbakkers, EM Wiegman, ... Journal of Nuclear Medicine 54 (8), 1175-1180, 2013 | 91 | 2013 |
| Calibration of gamma camera systems for a multicentre European 123I-FP-CIT SPECT normal database L Tossici-Bolt, JC Dickson, T Sera, R de Nijs, MC Bagnara, C Jonsson, ... European journal of nuclear medicine and molecular imaging 38, 1529-1540, 2011 | 90 | 2011 |
| Quantifying SV2A density and drug occupancy in the human brain using [11C]UCB-J PET imaging and subcortical white matter as reference tissue M Koole, J van Aalst, M Devrome, N Mertens, K Serdons, B Lacroix, ... European journal of nuclear medicine and molecular imaging 46, 396-406, 2019 | 83 | 2019 |
| Preclinical evaluation of a P2X7 receptor–selective radiotracer: PET studies in a rat model with local overexpression of the human P2X7 receptor and in nonhuman primates D Ory, S Celen, R Gijsbers, C Van Den Haute, A Postnov, M Koole, ... Journal of Nuclear Medicine 57 (9), 1436-1441, 2016 | 83 | 2016 |
| Dynamics of tumor hypoxia assessed by 18F-FAZA PET/CT in head and neck and lung cancer patients during chemoradiation: possible implications for radiotherapy treatment planning … VR Bollineni, MJB Koole, J Pruim, CL Brouwer, EM Wiegman, HJM Groen, ... Radiotherapy and Oncology 113 (2), 198-203, 2014 | 78 | 2014 |
| Preclinical evaluation of 18F-JNJ64349311, a novel PET tracer for tau imaging L Declercq, F Rombouts, M Koole, K Fierens, J Mariën, X Langlois, ... Journal of nuclear medicine 58 (6), 975-981, 2017 | 77 | 2017 |
| Whole-Body Biodistribution and Radiation Dosimetry of the Cannabinoid Type 2 Receptor Ligand [11C]-NE40 in Healthy Subjects R Ahmad, M Koole, N Evens, K Serdons, A Verbruggen, G Bormans, ... Molecular imaging and biology 15, 384-390, 2013 | 77 | 2013 |
| [18F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [68Ga]Ga-DOTATATE in neuroendocrine tumour patients E Pauwels, F Cleeren, T Tshibangu, M Koole, K Serdons, J Dekervel, ... European Journal of Nuclear Medicine and Molecular Imaging 47, 3033-3046, 2020 | 73 | 2020 |
| Preclinical evaluation of 18F-JNJ41510417 as a radioligand for PET imaging of phosphodiesterase-10A in the brain S Celen, M Koole, M De Angelis, I Sannen, SK Chitneni, J Alcazar, ... Journal of nuclear medicine 51 (10), 1584-1591, 2010 | 71 | 2010 |
| 18F-JNJ-64413739, a novel PET ligand for the P2X7 ion channel: radiation dosimetry, kinetic modeling, test-retest variability, and occupancy of the P2X7 antagonist JNJ-54175446 M Koole, ME Schmidt, A Hijzen, P Ravenstijn, C Vandermeulen, ... Journal of Nuclear Medicine 60 (5), 683-690, 2019 | 67 | 2019 |
